查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1224649

北美體外診斷市場規模、份額和趨勢分析報告：按產品（設備、試劑、服務）、技術、應用、最終用途、測試地點、地區、細分市場預測，2023-2030 年

North America In Vitro Diagnostics Market Size, Share & Trends Analysis Report By Product (Instruments, Reagents, Services), By Technology, By Application, By End-use, By Test Location, By Region, And Segment Forecasts, 2023 - 2030
出版日期: | 出版商: Grand View Research | 英文 280 Pages | 商品交期: 2-10個工作天內

價格

北美體外診斷市場的增長和趨勢

根據 Grand View Research, Inc. 的最新報告，北美體外診斷市場規模預計到 2030 年將達到 396.7 億美元，2023 年至 2030 年的複合年增長率為 2.89%。我來了。 同時，市場也有望在關鍵領域迎來各種增長機會。 例如，為醫院和實驗室開發自動化體外診斷解決方案以提供準確、高效和無差錯的診斷，預計將在未來幾年推動市場增長。 此外，開發 POC 解決方案的努力不斷增加，以及在傳染病、妊娠和癌症等各種醫學診斷應用中採用 POC 測試的激增正在推動市場的增長。

主要進入者加大力度開發快速準確的產品，以實現易於使用、先進和靈活的檢測選項，預計這將推動市場增長。 例如，2022 年 8 月，DxGen Corp. 和 Precision Diabetes, Inc. 宣布達成協議，將在美國市場開發和推出用於糖尿病檢測的全自動 POC 分析儀。 該分析儀可以在 POC 設施進行 CRP、尿液分析、A1C 值和其他糖尿病確認測試。

此外，2021 年 11 月，領先的 POC 診斷公司 Lumos Diagnostics 宣布 Lumos CoviDx SARS-CoV-2 快速抗原檢測獲得加拿大衛生部的中單授權。 該測試在無症狀患者的連續測試中僅需 15-20 分鐘即可提供易於解釋的結果。 家庭保健、社區藥房、零售診所、急救醫療中心、重症監護病房和手術室中即時檢測的便捷可用性正在推動 POC IVD 產品在該地區的廣泛採用。

隨著診斷實驗室頻繁採用全自動工具，北美體外診斷行業的發展勢頭越來越好。 此外，自動化設備具有高度可擴展性，滿足高性能期望，消除批量測試，並為醫療保健專業人員提供快速結果。 由於這些優勢，領先的參與者不斷致力於構建自動化設備。 例如，2022年5月，BD在美國市場推出了全新的全自動高通量傳染病分子診斷平台。

此外，該地區目標疾病發病率的增加、有利的政府舉措以及蓬勃發展的醫療保健行業預計將提供有利可圖的增長機會。

例如，2022 年 11 月，Hologic 從 BARDA 獲得了一份價值 1900 萬美元的合同，以支持其研發活動。 同樣在 2022 年 1 月，Aline, Inc. 和 Nectar Product Development 宣佈建立戰略合作夥伴關係，以改進 POC 體外診斷。

北美體外診斷市場報告要點

試劑行業在 2022 年佔據了最大的市場份額，這是由於主要市場參與者為開發新型檢測試劑盒採取了廣泛的研發舉措

由於技術的快速發展、疾病負擔的增加以及主要進入者產品發布的激增，分子診斷領域在 2022 年佔據了最大的市場份額

按應用劃分，傳染病領域將在 2022 年的收入份額方面佔據市場主導地位。 另一方面，腫瘤部分預計在預測期內增長最快

由於對負擔得起的服務的需求不斷增加、個性化護理趨勢激增、優惠報銷政策的存在等，到 2022 年，醫院部門將成為最大的最終用戶。

由於老年人口不斷增加，患者人數眾多，慢性病患病率高，預計加拿大在預測期內將出現最快的增長

Contents

第一章調查方法及範圍

  • 市場細分和範圍
  • 調查方法
  • 信息採購
    • 購買的數據庫：
    • GVR 內部數據庫
    • 次要信息
    • 初步調查
  • 信息或數據分析
    • 數據分析模型
  • 市場製定和驗證
  • 模型詳細信息
    • 商品流分析（模型 1）
      • 方法 1：商品流方法
  • 調查假設
  • 次要信息列表
  • 縮寫列表
  • 目的

第 2 章執行摘要

  • 市場概況
  • 片段快照
  • 競爭格局快照

第 3 章北美體外診斷市場變量、趨勢和範圍

  • 體外診斷市場體系展望
    • 母公司市場展望
  • 描繪滲透率和增長前景
  • 市場驅動因素分析
    • 不斷增長的老年人口
    • 技術進步
    • 對 POC 設施的需求增加
    • 目標疾病的患病率，例如遺傳病、心血管疾病、神經系統疾病和院內感染
    • COVID-19 爆發
  • 市場製約因素分析
    • 設備成本高
    • 嚴格的監管政策
  • SWOT 分析，按因素（政治和法律、經濟、技術）
  • 波特的五力分析
  • 管道階段分析
  • 監管和報銷方案
  • 價格分析

第 4 章北美體外診斷市場細分分析，副產品，2018-2030（數量、測試和儀器數量、收入，百萬美元，2018-2030）

  • 北美體外診斷市場：產品差異分析
  • 設備
    • 醫院
    • 實驗室
    • 家庭護理
    • 診所
      • 醫務室
      • 藥房和零售診所
      • 非臨床
      • 緊急治療門診
      • 其他
  • 試劑
    • 醫院
    • 實驗室
    • 家庭護理
    • 診所
      • 醫務室
      • 藥房和零售診所
      • 非臨床
      • 緊急治療門診
      • 其他
  • 服務
    • 醫院
    • 實驗室
    • 家庭護理
    • 診所
      • 醫務室
      • 藥房和零售診所
      • 非臨床
      • 緊急治療門診
      • 其他

第 5 章北美體外診斷市場細分分析，按技術分類，2018-2030 年（收入，百萬美元）（數量、測試數量和設備）

  • 北美體外診斷市場：技術波動分析
  • 免疫測定
    • 產品
      • 設備
      • 試劑
      • 服務
    • 最終用途
      • 醫院
      • 實驗室
      • 家庭護理
      • 診所
      • 醫務室
      • 藥房和零售診所
      • 非臨床
      • 緊急治療門診
      • 其他
  • 血液學
    • 產品
      • 設備
      • 試劑
      • 服務
    • 最終用途
      • 醫院
      • 實驗室
      • 家庭護理
      • 診所
      • 醫務室
      • 藥房和零售診所
      • 非臨床
      • 緊急治療門診
      • 其他
  • 臨床化學
    • 產品
      • 設備
      • 試劑
      • 服務
    • 最終用途
      • 醫院
      • 實驗室
      • 家庭護理
      • 診所
      • 醫務室
      • 藥房和零售診所
      • 非臨床
      • 緊急治療門診
      • 其他
  • 分子診斷
    • 產品
      • 設備
      • 試劑
      • 服務
    • 最終用途
      • 醫院
      • 實驗室
      • 家庭護理
      • 診所
      • 醫務室
      • 藥房和零售診所
      • 非臨床
      • 緊急治療門診
      • 其他
  • 凝血
    • 產品
      • 設備
      • 試劑
      • 服務
    • 最終用途
      • 醫院
      • 實驗室
      • 家庭護理
      • 診所
      • 醫務室
      • 藥房和零售診所
      • 非臨床
      • 緊急治療門診
      • 其他
  • 微生物學
    • 產品
      • 設備
      • 試劑
      • 服務
    • 最終用途
      • 醫院
      • 實驗室
      • 家庭護理
      • 診所
      • 醫務室
      • 藥房和零售診所
      • 非臨床
      • 緊急治療門診
      • 其他
  • 其他
    • 設備
    • 試劑
    • 服務

第 6 章北美體外診斷市場：細分分析，按應用，2018-2030（百萬美元）

  • 北美體外診斷市場：應用差異分析
  • 感染
    • 疾病
      • 耐甲氧西林金黃色葡萄球菌 (Mrsa)
      • 艱難梭菌
      • 耐萬古黴素腸球菌 (Vre)
      • 耐碳青黴烯類細菌
Product Code: GVR-4-68040-028-3

North America In Vitro Diagnostics Market Growth & Trends:

The North America in vitro diagnostics market size is expected to reach USD 39.67 billion by 2030 and is expected to decline at 2.89% CAGR from 2023 to 2030, according to a new report by Grand View Research, Inc. On the other hand, the market is also expected to cater to various growth opportunities in key segments. For example, the development of automated in vitro diagnostic solutions for hospitals and laboratories to provide accurate, efficient, and error-free diagnosis is anticipated to drive market growth in the coming years. In addition, rising efforts to develop POC solutions and the surge in adoption of POC tests across different medical diagnostic applications, including infectious diseases, pregnancy, cancer, and others, are fueling the market growth.

The market growth is likely to be fueled by rising efforts from leading participants to develop fast and accurate products that allow easy-to-use, advanced, and flexible testing options. For instance, in August 2022, DxGen Corp. and Precision Diabetes, Inc. announced an agreement to develop and launch a fully automatic POC analyzer in the U.S. market to measure a complete profile of diabetes tests. The analyzer is capable to test C-reactive protein, urine analysis, A1C levels, and other diabetes confirmatory tests at POC facilities.

Furthermore, in November 2021, Lumos Diagnostics, a key player in POC diagnostics, announced that its Lumos CoviDx SARS-CoV-2 Rapid Antigen Test received an interim order authorization from Health Canada. This test offers easy-to-interpret outcomes in just 15-20 minutes in serial testing of asymptomatic patients. The easy availability of point-of-care tests in home care settings, community pharmacies, retail health clinics, urgent care centers, intensive care units, and operating rooms is fueling the adoption of POC IVD products across the region.

The North America in vitro diagnostics industry is gaining traction as diagnostic laboratories frequently employ fully automated tools. Moreover, automated devices are highly scalable, meet a high level of performance expectations, eliminate batch testing, and provide quick results to medical professionals. Leading participants are continuously working on building automated devices because of these benefits. For instance, in May 2022, BD launched a new, fully automated high-throughput infectious disease molecular diagnostics platform in the U.S. market.

Furthermore, the increasing incidence of target diseases, favorable government initiatives, and the flourishing healthcare sector in the region are anticipated to offer lucrative growth opportunities.

For instance, in November 2022, Hologic, Inc. was awarded a USD 19 million contract from BARDA to support its research and development activities. In addition, in January 2022, Aline, Inc. & Nectar Product Development announced a strategic partnership to improve POC in vitro diagnostic products.

North America In Vitro Diagnostics Market Report Highlights:

  • The reagents segment held the largest market share in 2022 owing to extensive R&D initiatives being undertaken by major market players for the development of novel test kits
  • The molecular diagnostics segment accounted for the largest market share in 2022, thanks to rapid evolution in technology, increasing burden of target diseases, and surge in product launches by leading participants
  • Based on application, the infectious disease segment dominated the market in terms of revenue share in 2022. On the other hand, the oncology segment is expected to be the fastest-growing segment over the forecast period
  • The hospitals segment was the largest end-user in 2022, owing to the rising demand for affordable services, the surging trend for personalized treatments, and the presence of favorable reimbursement policies
  • Canada is expected to exhibit the fastest growth over the forecast period in the region due to the increasing geriatric population, and large patient pool with a high prevalence of chronic diseases

Table of Contents

Chapter 1 Methodology And Scope

  • 1.1 Market Segmentation And Scope
    • 1.1.1 Estimates And Forecast Timeline
  • 1.2 Research Methodology
  • 1.3 Information Procurement
    • 1.3.1 Purchased Database:
    • 1.3.2 Gvr's Internal Database
    • 1.3.3 Secondary Sources
    • 1.3.4 Primary Research
  • 1.4 Information Or Data Analysis
    • 1.4.1 Data Analysis Models
  • 1.5 Market Formulation & Validation
  • 1.6 Model Details
    • 1.6.1 Commodity Flow Analysis (Model 1)
      • 1.6.1.1 Approach 1: Commodity Flow Approach
  • 1.7 Research Assumptions
  • 1.8 List Of Secondary Sources
  • 1.9 List Of Abbreviations
  • 1.10 Objectives
    • 1.10.1 Objective 1
    • 1.10.2 Objective 2
    • 1.10.3 Objective 3
    • 1.10.4 Objective 4

Chapter 2 Executive Summary

  • 2.1 Market Snapshot
  • 2.2 Segment Snapshot
  • 2.3 Competitive Landscape Snapshot

Chapter 3 North America Ivd Market Variables, Trends, & Scope

  • 3.1 Ivd Market Lineage Outlook
    • 3.1.1 Parent Market Outlook
  • 3.2 Penetration And Growth Prospect Mapping
  • 3.3 Market Driver Analysis
    • 3.3.1 Growing Geriatric Population
    • 3.3.2 Technological Advancements
    • 3.3.3 Increasing Demand For Poc Facilities
    • 3.3.4 Growing Prevalence Of Target Diseases Such As Genetic, Cardiovascular, & Neurological Diseases And Hospital-Acquired Infections
    • 3.3.5 Outbreak Of Covid-19
  • 3.4 Market Restraint Analysis
    • 3.4.1 High Cost Of Devices
    • 3.4.2 Stringent Regulatory Policies
  • 3.5 Swot Analysis, By Factor (Political & Legal, Economic, And Technological)
  • 3.6 Porter's Five Forces Analysis
  • 3.7 Pipeline Analysis, By Phase
  • 3.8 Regulatory & Reimbursement Scenario
  • 3.9 Pricing Analysis

Chapter 4 North America Ivd Market-Segment Analysis, By Product, 2018 - 2030 (Volume, Number Of Tests And Instruments; Revenue, USD Million, 2018 - 2030)

  • 4.1 North America In Vitro Diagnostic Market: Products Movement Analysis
  • 4.2 Instruments
    • 4.2.1 Instruments Market Estimates And Forecast, 2018 - 2030 (USD Million)
    • 4.2.2 Hospitals
      • 4.2.2.1 Hospitals Market Estimates And Forecast, 2018 - 2030 (USD Million)
    • 4.2.3 Laboratories
      • 4.2.3.1 Laboratories Market Estimates And Forecast, 2018 - 2030 (USD Million)
    • 4.2.4 Home Care
      • 4.2.4.1 Home Care Market Estimates And Forecast, 2018 - 2030 (USD Million)
    • 4.2.5 Clinic
      • 4.2.5.1 Clinic Market Estimates And Forecast, 2018 - 2030 (USD Million)
      • 4.2.5.2 Physician Office
      • 4.2.5.2.1 Physician Office Market Estimates And Forecast, 2018 - 2030 (USD Million)
      • 4.2.5.3 Pharmacy & Retail Clinics
      • 4.2.5.3.1 Pharmacy & Retail Clinics Market Estimates And Forecast, 2018 - 2030 (USD Million)
      • 4.2.5.4 Non-Practice Clinics
      • 4.2.5.4.1 Non-Practice Clinics Market Estimates And Forecast, 2018 - 2030 (USD Million)
      • 4.2.5.5 Urgent Care Clinics
      • 4.2.5.5.1 Urgent Care Clinics Market Estimates And Forecast, 2018 - 2030 (USD Million)
      • 4.2.5.6 Others
      • 4.2.5.6.1 Others Market Estimates And Forecast, 2018 - 2030 (USD Million)
  • 4.3 Reagents
    • 4.3.1 Reagents Market Estimates And Forecast, 2018 - 2030 (USD Million)
    • 4.3.2 Hospitals
      • 4.3.2.1 Hospitals Market Estimates And Forecast, 2018 - 2030 (USD Million)
    • 4.3.3 Laboratories
      • 4.3.3.1 Laboratories Market Estimates And Forecast, 2018 - 2030 (USD Million)
    • 4.3.4 Home Care
      • 4.3.4.1 Home Care Market Estimates And Forecast, 2018 - 2030 (USD Million)
    • 4.3.5 Clinic
      • 4.3.5.1 Clinic Market Estimates And Forecast, 2018 - 2030 (USD Million)
      • 4.3.5.2 Physician Office
      • 4.3.5.2.1 Physician Office Market Estimates And Forecast, 2018 - 2030 (USD Million)
      • 4.3.5.3 Pharmacy & Retail Clinics
      • 4.3.5.3.1 Pharmacy & Retail Clinics Market Estimates And Forecast, 2018 - 2030 (USD Million)
      • 4.3.5.4 Non-Practice Clinics
      • 4.3.5.4.1 Non-Practice Clinics Market Estimates And Forecast, 2018 - 2030 (USD Million)
      • 4.3.5.5 Urgent Care Clinics
      • 4.3.5.5.1 Urgent Care Clinics Market Estimates And Forecast, 2018 - 2030 (USD Million)
      • 4.3.5.6 Others
      • 4.3.5.6.1 Others Market Estimates And Forecast, 2018 - 2030 (USD Million)
  • 4.4 Services
    • 4.4.1 Services Market Estimates And Forecast, 2018 - 2030 (USD Million)
    • 4.4.2 Hospitals
      • 4.4.2.1 Hospitals Market Estimates And Forecast, 2018 - 2030 (USD Million)
    • 4.4.3 Laboratories
      • 4.4.3.1 Laboratories Market Estimates And Forecast, 2018 - 2030 (USD Million)
    • 4.4.4 Home Care
      • 4.4.4.1 Home Care Market Estimates And Forecast, 2018 - 2030 (USD Million)
    • 4.4.5 Clinic
      • 4.4.5.1 Clinic Market Estimates And Forecast, 2018 - 2030 (USD Million)
      • 4.4.5.2 Physician Office
      • 4.4.5.2.1 Physician Office Market Estimates And Forecast, 2018 - 2030 (USD Million)
      • 4.4.5.3 Pharmacy & Retail Clinics
      • 4.4.5.3.1 Pharmacy & Retail Clinics Market Estimates And Forecast, 2018 - 2030 (USD Million)
      • 4.4.5.4 Non-Practice Clinics
      • 4.4.5.4.1 Non-Practice Clinics Market Estimates And Forecast, 2018 - 2030 (USD Million)
      • 4.4.5.5 Urgent Care Clinics
      • 4.4.5.5.1 Urgent Care Clinics Market Estimates And Forecast, 2018 - 2030 (USD Million)
      • 4.4.5.6 Others
      • 4.4.5.6.1 Others Market Estimates And Forecast, 2018 - 2030 (USD Million)

Chapter 5 North America Ivd Market-Segment Analysis, By Technology, 2018 - 2030 (Revenue, USD Million) (Volume, Number Of Test And Instruments)

  • 5.1 North America In Vitro Diagnostics Market: Technology Movement Analysis
  • 5.2 Immunoassay
    • 5.2.1 Immunoassay Market Estimates And Forecast, 2018 - 2030 (USD Million)
    • 5.2.2 Products
      • 5.2.2.1 Instruments
      • 5.2.2.1.1 Instruments Market For Immunoassay Estimates And Forecast, 2018 - 2030 (USD Million)
      • 5.2.2.2 Reagents
      • 5.2.2.2.1 Reagents Market For Immunoassay Estimates And Forecast, 2018 - 2030 (USD Million)
      • 5.2.2.3 Services
      • 5.2.2.3.1 Services Market For Immunoassay Estimates And Forecast, 2018 - 2030 (USD Million)
    • 5.2.3 End-Use
      • 5.2.3.1 Hospitals
      • 5.2.3.1.1 Hospitals Market Estimates And Forecast, 2018 - 2030 (USD Million)
      • 5.2.3.2 Laboratories
      • 5.2.3.2.1 Laboratories Market Estimates And Forecast, 2018 - 2030 (USD Million)
      • 5.2.3.3 Home Care
      • 5.2.3.3.1 Home Care Market Estimates And Forecast, 2018 - 2030 (USD Million)
      • 5.2.3.4 Clinic
      • 5.2.3.4.1 Clinic Market Estimates And Forecast, 2018 - 2030 (USD Million)
      • 5.2.3.4.2 Physician Office
      • 5.2.3.4.2.1 Physician Office Market Estimates And Forecast, 2018 - 2030 (USD Million)
      • 5.2.3.4.3 Pharmacy & Retail Clinics
      • 5.2.3.4.3.1 Pharmacy & Retail Clinics Market Estimates And Forecast, 2018 - 2030 (USD Million)
      • 5.2.3.4.4 Non-Practice Clinics
      • 5.2.3.4.4.1 Non-Practice Clinics Market Estimates And Forecast, 2018 - 2030 (USD Million)
      • 5.2.3.4.5 Urgent Care Clinics
      • 5.2.3.4.5.1 Urgent Care Clinics Market Estimates And Forecast, 2018 - 2030 (USD Million)
      • 5.2.3.4.6 Others
      • 5.2.3.4.6.1 Others Market Estimates And Forecast, 2018 - 2030 (USD Million)
  • 5.3 Hematology
    • 5.3.1 Hematology Market Estimates And Forecast, 2018 - 2030 (USD Million)
    • 5.3.2 Products
      • 5.3.2.1 Instruments
      • 5.3.2.1.1 Instruments Market For Hematology Estimates And Forecast, 2018 - 2030 (USD Million)
      • 5.3.2.2 Reagents
      • 5.3.2.2.1 Reagents Market For Hematology Estimates And Forecast, 2018 - 2030 (USD Million)
      • 5.3.2.3 Services
      • 5.3.2.3.1 Services Market For Hematology Estimates And Forecast, 2018 - 2030 (USD Million)
    • 5.3.3 End-Use
      • 5.3.3.1 Hospitals
      • 5.3.3.1.1 Hospitals Market Estimates And Forecast, 2018 - 2030 (USD Million)
      • 5.3.3.2 Laboratories
      • 5.3.3.2.1 Laboratories Market Estimates And Forecast, 2018 - 2030 (USD Million)
      • 5.3.3.3 Home Care
      • 5.3.3.3.1 Home Care Market Estimates And Forecast, 2018 - 2030 (USD Million)
      • 5.3.3.4 Clinic
      • 5.3.3.4.1 Clinic Market Estimates And Forecast, 2018 - 2030 (USD Million)
      • 5.3.3.4.2 Physician Office
      • 5.3.3.4.2.1 Physician Office Market Estimates And Forecast, 2018 - 2030 (USD Million)
      • 5.3.3.4.3 Pharmacy & Retail Clinics
      • 5.3.3.4.3.1 Pharmacy & Retail Clinics Market Estimates And Forecast, 2018 - 2030 (USD Million)
      • 5.3.3.4.4 Non-Practice Clinics
      • 5.3.3.4.4.1 Non-Practice Clinics Market Estimates And Forecast, 2018 - 2030 (USD Million)
      • 5.3.3.4.5 Urgent Care Clinics
      • 5.3.3.4.5.1 Urgent Care Clinics Market Estimates And Forecast, 2018 - 2030 (USD Million)
      • 5.3.3.4.6 Others
      • 5.3.3.4.6.1 Others Market Estimates And Forecast, 2018 - 2030 (USD Million)
  • 5.4 Clinical Chemistry
    • 5.4.1 Clinical Chemistry Market Estimates And Forecast, 2018 - 2030 (USD Million)
    • 5.4.2 Products
      • 5.4.2.1 Instruments
      • 5.4.2.1.1 Instruments Market For Clinical Chemistry Estimates And Forecast, 2018 - 2030 (USD Million)
      • 5.4.2.2 Reagents
      • 5.4.2.2.1 Reagents Market For Clinical Chemistry Estimates And Forecast, 2018 - 2030 (USD Million)
      • 5.4.2.3 Services
      • 5.4.2.3.1 Services Market For Clinical Chemistry Estimates And Forecast, 2018 - 2030 (USD Million)
    • 5.4.3 End-Use
      • 5.4.3.1 Hospitals
      • 5.4.3.1.1 Hospitals Market Estimates And Forecast, 2018 - 2030 (USD Million)
      • 5.4.3.2 Laboratories
      • 5.4.3.2.1 Laboratories Market Estimates And Forecast, 2018 - 2030 (USD Million)
      • 5.4.3.3 Home Care
      • 5.4.3.3.1 Home Care Market Estimates And Forecast, 2018 - 2030 (USD Million)
      • 5.4.3.4 Clinic
      • 5.4.3.4.1 Clinic Market Estimates And Forecast, 2018 - 2030 (USD Million)
      • 5.4.3.4.2 Physician Office
      • 5.4.3.4.2.1 Physician Office Market Estimates And Forecast, 2018 - 2030 (USD Million)
      • 5.4.3.4.3 Pharmacy & Retail Clinics
      • 5.4.3.4.3.1 Pharmacy & Retail Clinics Market Estimates And Forecast, 2018 - 2030 (USD Million)
      • 5.4.3.4.4 Non-Practice Clinics
      • 5.4.3.4.4.1 Non-Practice Clinics Market Estimates And Forecast, 2018 - 2030 (USD Million)
      • 5.4.3.4.5 Urgent Care Clinics
      • 5.4.3.4.5.1 Urgent Care Clinics Market Estimates And Forecast, 2018 - 2030 (USD Million)
      • 5.4.3.4.6 Others
      • 5.4.3.4.6.1 Others Market Estimates And Forecast, 2018 - 2030 (USD Million)
  • 5.5 Molecular Diagnostics
    • 5.5.1 Molecular Diagnostics Market Estimates And Forecast, 2018 - 2030 (USD Million)
    • 5.5.2 Products
      • 5.5.2.1 Instruments
      • 5.5.2.1.1 Instruments Market For Molecular Diagnostics Estimates And Forecast, 2018 - 2030 (USD Million)
      • 5.5.2.2 Reagents
      • 5.5.2.2.1 Reagents Market For Molecular Diagnostics Estimates And Forecast, 2018 - 2030 (USD Million)
      • 5.5.2.3 Services
      • 5.5.2.3.1 Services Market For Molecular Diagnostics Estimates And Forecast, 2018 - 2030 (USD Million)
    • 5.5.3 End-Use
      • 5.5.3.1 Hospitals
      • 5.5.3.1.1 Hospitals Market Estimates And Forecast, 2018 - 2030 (USD Million)
      • 5.5.3.2 Laboratories
      • 5.5.3.2.1 Laboratories Market Estimates And Forecast, 2018 - 2030 (USD Million)
      • 5.5.3.3 Home Care
      • 5.5.3.3.1 Home Care Market Estimates And Forecast, 2018 - 2030 (USD Million)
      • 5.5.3.4 Clinic
      • 5.5.3.4.1 Clinic Market Estimates And Forecast, 2018 - 2030 (USD Million)
      • 5.5.3.4.2 Physician Office
      • 5.5.3.4.2.1 Physician Office Market Estimates And Forecast, 2018 - 2030 (USD Million)
      • 5.5.3.4.3 Pharmacy & Retail Clinics
      • 5.5.3.4.3.1 Pharmacy & Retail Clinics Market Estimates And Forecast, 2018 - 2030 (USD Million)
      • 5.5.3.4.4 Non-Practice Clinics
      • 5.5.3.4.4.1 Non-Practice Clinics Market Estimates And Forecast, 2018 - 2030 (USD Million)
      • 5.5.3.4.5 Urgent Care Clinics
      • 5.5.3.4.5.1 Urgent Care Clinics Market Estimates And Forecast, 2018 - 2030 (USD Million)
      • 5.5.3.4.6 Others
      • 5.5.3.4.6.1 Others Market Estimates And Forecast, 2018 - 2030 (USD Million)
  • 5.6 Coagulation
    • 5.6.1 Coagulation Market Estimates And Forecast, 2018 - 2030 (USD Million)
    • 5.6.2 Products
      • 5.6.2.1 Instruments
      • 5.6.2.1.1 Instruments Market For Coagulation Estimates And Forecast, 2018 - 2030 (USD Million)
      • 5.6.2.2 Reagents
      • 5.6.2.2.1 Reagents Market For Coagulation Estimates And Forecast, 2018 - 2030 (USD Million)
      • 5.6.2.3 Services
      • 5.6.2.3.1 Services Market For Coagulation Estimates And Forecast, 2018 - 2030 (USD Million)
    • 5.6.3 End-Use
      • 5.6.3.1 Hospitals
      • 5.6.3.1.1 Hospitals Market Estimates And Forecast, 2018 - 2030 (USD Million)
      • 5.6.3.2 Laboratories
      • 5.6.3.2.1 Laboratories Market Estimates And Forecast, 2018 - 2030 (USD Million)
      • 5.6.3.3 Home Care
      • 5.6.3.3.1 Home Care Market Estimates And Forecast, 2018 - 2030 (USD Million)
      • 5.6.3.4 Clinic
      • 5.6.3.4.1 Clinic Market Estimates And Forecast, 2018 - 2030 (USD Million)
      • 5.6.3.4.2 Physician Office
      • 5.6.3.4.2.1 Physician Office Market Estimates And Forecast, 2018 - 2030 (USD Million)
      • 5.6.3.4.3 Pharmacy & Retail Clinics
      • 5.6.3.4.3.1 Pharmacy & Retail Clinics Market Estimates And Forecast, 2018 - 2030 (USD Million)
      • 5.6.3.4.4 Non-Practice Clinics
      • 5.6.3.4.4.1 Non-Practice Clinics Market Estimates And Forecast, 2018 - 2030 (USD Million)
      • 5.6.3.4.5 Urgent Care Clinics
      • 5.6.3.4.5.1 Urgent Care Clinics Market Estimates And Forecast, 2018 - 2030 (USD Million)
      • 5.6.3.4.6 Others
      • 5.6.3.4.6.1 Others Market Estimates And Forecast, 2018 - 2030 (USD Million)
  • 5.7 Microbiology
    • 5.7.1 Microbiology Market Estimates And Forecast, 2018 - 2030 (USD Million)
    • 5.7.2 Products
      • 5.7.2.1 Instruments
      • 5.7.2.1.1 Instruments Market For Microbiology Estimates And Forecast, 2018 - 2030 (USD Million)
      • 5.7.2.2 Reagents
      • 5.7.2.2.1 Reagents Market For Microbiology Estimates And Forecast, 2018 - 2030 (USD Million)
      • 5.7.2.3 Services
      • 5.7.2.3.1 Services Market For Microbiology Estimates And Forecast, 2018 - 2030 (USD Million)
    • 5.7.3 End-Use
      • 5.7.3.1 Hospitals
      • 5.7.3.1.1 Hospitals Market Estimates And Forecast, 2018 - 2030 (USD Million)
      • 5.7.3.2 Laboratories
      • 5.7.3.2.1 Laboratories Market Estimates And Forecast, 2018 - 2030 (USD Million)
      • 5.7.3.3 Home Care
      • 5.7.3.3.1 Home Care Market Estimates And Forecast, 2018 - 2030 (USD Million)
      • 5.7.3.4 Clinic
      • 5.7.3.4.1 Clinic Market Estimates And Forecast, 2018 - 2030 (USD Million)
      • 5.7.3.4.2 Physician Office
      • 5.7.3.4.2.1 Physician Office Market Estimates And Forecast, 2018 - 2030 (USD Million)
      • 5.7.3.4.3 Pharmacy & Retail Clinics
      • 5.7.3.4.3.1 Pharmacy & Retail Clinics Market Estimates And Forecast, 2018 - 2030 (USD Million)
      • 5.7.3.4.4 Non-Practice Clinics
      • 5.7.3.4.4.1 Non-Practice Clinics Market Estimates And Forecast, 2018 - 2030 (USD Million)
      • 5.7.3.4.5 Urgent Care Clinics
      • 5.7.3.4.5.1 Urgent Care Clinics Market Estimates And Forecast, 2018 - 2030 (USD Million)
      • 5.7.3.4.6 Others
      • 5.7.3.4.6.1 Others Market Estimates And Forecast, 2018 - 2030 (USD Million)
  • 5.8 Others
    • 5.8.1 Others Market Estimates And Forecast, 2018 - 2030 (USD Million)
    • 5.8.2 Instruments
      • 5.8.2.1 Instruments Market Estimates And Forecast, 2018 - 2030 (USD Million)
    • 5.8.3 Reagents
      • 5.8.3.1 Reagents Market Estimates And Forecast, 2018 - 2030 (USD Million)
    • 5.8.4 Services
      • 5.8.4.1 Services Market Estimates And Forecast, 2018 - 2030 (USD Million)

Chapter 6 North America Ivd Market: Segment Analysis, By Application, 2018 - 2030 (USD Million)

  • 6.1 North America In Vitro Diagnostics Market: Application Movement Analysis
  • 6.2 Infectious Diseases
    • 6.2.1 Infectious Diseases Market Estimates And Forecast, 2018 - 2030 (USD Million)
    • 6.2.2 Disease
      • 6.2.2.1. Methicillin-Resistant Staphylococcus Aureus (Mrsa)
      • 6.2.2.1.1 Methicillin-Resistant Staphylococcus Aureus (Mrsa) Market Estimates And Forecast, 2018 - 2030 (USD Million)
      • 6.2.2.1.2 Clostridium Difficile
      • 6.2.2.1.2.1 Clostridium Difficile Market Estimates And Forecast, 2018 - 2030 (USD Million)
      • 6.2.2.1.3 Vancomycin-Resistant Enterococci (Vre)
      • 6.2.2.1.3.1 Vancomycin-Resistant Enterococci (Vre) Market Estimates And Forecast, 2018 - 2030 (USD Million)
      • 6.2.2.1.4 Carbapenem-Resistant Bacteria
      • 6.2.2.1.4.1 Carbapenem-Resistant Bacteria Market Estimates And Forecast, 2018 - 2030 (USD Million)

List of Tables

  • Table 1 List of Secondary Sources
  • Table 2 List of Abbreviations
  • Table 3 Leading Market Players Anticipated to Witness Highest Growth
  • Table 4 North America In Vitro Diagnostics Market, By Country, 2018 - 2030 (USD Million)
  • Table 5 North America In Vitro Diagnostics Market, By Product, 2018 - 2030 (USD Million) (Number of Tests & Instruments)
  • Table 6 North America In Vitro Diagnostics Market, By Technology, 2018 - 2030 (USD Million) (Number of Tests & Instruments)
  • Table 7 North America In Vitro Diagnostics Market, By Route of Application, 2018 - 2030 (USD Million)
  • Table 8 North America In Vitro Diagnostics Market, By End-Use, 2018 - 2030 (USD Million) (Number of Tests & Instruments)
  • Table 9 North America In Vitro Diagnostics Market, By Test Location, 2018 - 2030 (USD Million)
  • Table 10 U.S. In Vitro Diagnostics Market, By Product, 2018 - 2030 (USD Million) (Number of Tests & Instruments)
  • Table 11 U.S. In Vitro Diagnostics Market, By Technology, 2018 - 2030 (USD Million) (Number of Tests & Instruments)
  • Table 12 U.S. In Vitro Diagnostics Market, By Route of Application, 2018 - 2030 (USD Million)
  • Table 13 U.S. In Vitro Diagnostics Market, By End-Use, 2018 - 2030 (USD Million) (Number of Tests & Instruments)
  • Table 14 U.S. In Vitro Diagnostics Market, By Test Location, 2018 - 2030 (USD Million)
  • Table 15 Canada In Vitro Diagnostics Market, By Product, 2018 - 2030 (USD Million) (Number of Tests & Instruments)
  • Table 16 Canada In Vitro Diagnostics Market, By Technology, 2018 - 2030 (USD Million) (Number of Tests & Instruments)
  • Table 17 Canada In Vitro Diagnostics Market, By Route of Application, 2018 - 2030 (USD Million)
  • Table 18 Canada In Vitro Diagnostics Market, By End-Use, 2018 - 2030 (USD Million) (Number of
  • Table 19 Canada In Vitro Diagnostics Market, By Test Location, 2018 - 2030 (USD Million)

List of Figures

  • Fig. 1 North America in vitro diagnostics market segmentation
  • Fig. 2 Market research process
  • Fig. 3 Information procurement
  • Fig. 4 Primary research pattern
  • Fig. 5 Market research approaches
  • Fig. 6 Value-chain-based sizing & forecasting
  • Fig. 7 QFD modeling for market share assessment
  • Fig. 8 Market formulation & validation
  • Fig. 9 Market snapshot
  • Fig. 10 Segment snapshot
  • Fig. 11 Segment snapshot
  • Fig. 12 Segment snapshot
  • Fig. 13 Competitive landscape snapshot
  • Fig. 14 Penetration and growth prospect mapping
  • Fig. 15 North America in vitro diagnostic market driver impact
  • Fig. 16 Geriatric population in the U.S.
  • Fig. 17 Comparison of geriatric population in the U.S.
  • Fig. 18 Proportion of Canadian population in 2022
  • Fig. 19 Number of deaths for leading causes of death
  • Fig. 20 North America in vitro diagnostics market restraint impact
  • Fig. 21 SWOT analysis, by factor (political & legal, economic, and technological)
  • Fig. 22 Porter's five forces analysis
  • Fig. 23 Taking control of the changing regulatory landscape
  • Fig. 24 North America IVD market: Product outlook and key takeaways
  • Fig. 25 North America. IVD market: Products movement analysis
  • Fig. 26 Instruments market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 27 Hospitals market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 28 Laboratories market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 29 Home care market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 30 Clinic market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 31 Physician office market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 32 Pharmacy & retail clinics market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 33 Non-practice clinics market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 34 Urgent care clinics market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 35 Others market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 36 Reagents market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 37 Hospitals market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 38 Laboratories market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 39 Home care market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 40 Clinic market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 41 Physician office market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 42 Pharmacy & retail clinics market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 43 Non-practice clinics market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 44 Urgent care clinics market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 45 Others market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 46 Services market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 47 Hospitals market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 48 Laboratories market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 49 Home care market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 50 Clinic market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 51 Physician office market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 52 Pharmacy & retail clinics market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 53 Non-practice clinics market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 54 Urgent care clinics market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 55 Others market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 56 North America IVD market: Technology outlook and key takeaways
  • Fig. 57 North America IVD market: Technology movement analysis
  • Fig. 58 Immunoassay market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 59 Instruments market for immunoassay estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 60 Reagents market for immunoassay estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 61 Services market for immunoassay estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 62 Hospitals market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 63 Laboratories market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 64 Instruments market for clinical chemistry estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 65 Pharmacy & retail clinics market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 66 Services market for other technology estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 67 North America IVD market: Application outlook and key takeaways
  • Fig. 68 North America IVD market: Application movement analysis
  • Fig. 69 Meningitis market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 70 Percentage of osteoporosis affecting men and women
  • Fig. 71 North America IVD market: End-use outlook and key takeaways
  • Fig. 72 Home care market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 73 Key stats related to retail clinics in the U.S.
  • Fig. 74 Regional marketplace: Key takeaways
  • Fig. 75 North America: SWOT analysis
  • Fig. 76 North America IVD market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 77 Key country dynamics
  • Fig. 78 Risk factors and major chronic diseases in the U.S.
  • Fig. 79 U.S. healthcare reimbursement and financing structure
  • Fig. 80 U.S. IVD market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 81 Key country dynamics
  • Fig. 82 Target disease prevalence in Canada
  • Fig. 83 Canada IVD market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 84 Market participant categorization
  • Fig. 85 North America IVD market share analysis, 2022
  • Fig. 86 Strategic framework
  • Fig. 87 Competition categorization
  • Fig. 88 Company market position analysis
  • Fig. 89 Company market position analysis
  • Fig. 90 Company market position analysis
  • Fig. 91 Regional network map